Trusted Resource for Clinical Trials, Protocols & Progress
Traditional clinical data capture involves batch uploads, delayed site monitoring, and manual reconciliation of logs. As trials become decentralized and digital endpoints more prevalent, this model is insufficient. Real-time monitoring via cloud-based platforms is transforming clinical operations by enabling proactive oversight, immediate intervention, and continuous data availability.
Click to read the full article.
Wearables produce rich and continuous streams of physiological data—from heart rate and sleep to movement and electrodermal activity. While this opens new frontiers for endpoint development and real-time monitoring, it also presents significant statistical challenges: noise, missing data, inter-patient variability, and complex time structures.
Click to read the full article.
As clinical trials evolve toward decentralization and remote monitoring, wearables now generate a torrent of continuous physiological and behavioral data. While this real-time visibility enhances safety and patient-centricity, it poses challenges in interpretation, scalability, and actionability.
Click to read the full article.
The rise of wearable sensors, ePROs, and mobile apps in clinical trials has led to an explosion of data—continuous, high-frequency, and multidimensional. While this information is rich in clinical potential, it remains useless without effective visualization.
Click to read the full article.
As decentralized clinical trials (DCTs) and connected health models mature, sponsors are faced with a new kind of operational challenge—handling massive volumes of streaming data from wearable devices, home monitors, and smartphone sensors. These devices can generate thousands of records per patient per day, leading to terabytes of real-time telemetry across trial populations.
Click to read the full article.
In modern clinical trials, wearables don’t just capture one variable—they monitor multiple physiological parameters simultaneously. From heart rate (HR) and respiration to motion, temperature, and SpO₂, these sensors offer a rich, continuous stream of data. However, interpreting this multi-modal input effectively requires more than basic analysis.
Click to read the full article.
As sponsors increasingly adopt digital health technologies (DHTs) like wearables, biosensors, and mobile apps in clinical trials, the U.S. Food and Drug Administration (FDA) has released specific guidance to help industry align with regulatory expectations. These tools offer promising avenues for patient-centric, remote, and real-world data collection, but must comply with rigorous standards to ensure safety, reliability, and clinical relevance.
Click to read the full article.
The integration of wearable devices in clinical trials has transformed how patient data is captured—enabling passive, real-time, and remote monitoring. However, this innovation introduces new regulatory complexities, particularly around Good Clinical Practice (GCP) compliance.
Click to read the full article.
Wearables have become a vital tool in modern clinical research, enabling real-time data capture, continuous monitoring, and improved patient engagement. However, their integration into clinical trials necessitates clear and compliant informed consent language to ensure participants understand what is being collected, how it will be used, and their rights concerning the data.
Click to read the full article.
With the rise of wearable devices in clinical trials, regulatory authorities have increased focus on how these digital health technologies (DHTs) generate, store, and transfer source data. For pharma sponsors and CROs, ensuring auditability and source data validation is essential for GCP compliance, regulatory acceptance, and maintaining data integrity.
Click to read the full article.
